ロード中...
Prefusion F-based polyanhydride nanovaccine induces both humoral and cell-mediated immunity resulting in long-lasting protection against respiratory syncytial virus
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in both young children and in older adults. Despite the morbidity, mortality, and high economic burden caused by RSV worldwide, no licensed vaccine is currently available. We have developed a novel RSV vaccine...
保存先:
| 出版年: | J Immunol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8062305/ https://ncbi.nlm.nih.gov/pubmed/33827894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2100018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|